Patel chem specialities limited IPO Overview
Patel chem specialities limited IPO is a SME public issue offered through a Book Building issue with a total issue size of ₹— crores. The IPO price band is set at ₹84 per share, and retail investors can apply with a minimum investment of ₹2.69 L as per IPO guidelines.
The Patel chem specialities limited IPO opens on 25 Jul 2025 and closes on 29 Jul 2025. The IPO allotment is expected to be finalized on 30 Jul 2025, and the equity shares are proposed to be listed on BSE on 1 Aug 2025.
Investors can refer to the Patel chem specialities limited IPO RHP-DRHP for detailed information. The issue is managed by Cumulative Capital Private Limited,Unistone Capital Pvt Ltd as the book running lead manager, while MUFG Intime India Private Limited (Link Intime) is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About patel chem specialities limited
The company manufactures various essential chemicals used in pharmaceuticals, food, cosmetics, and industrial applications, serving as binders, disintegrants, thickeners, stabilizers, and gelling agents across industries.
The company’s manufacturing facilities in Vatva, Ahmedabad, and Talod, Himmatnagar, follow strict quality control standards, ensuring bulk production of chemicals that meet international certifications like US-DMF and GMP.
The company’s manufacturing facility covers 7,000 square yards, with a capacity of over 7,200 MT annually for pharmaceutical excipients, featuring departments for storage, production, R&D, quality control, packaging, and warehousing.
The company has expanded globally, serving East Asia, Europe, the Middle East, North America, and Southeast Asia, delivering high-quality products that meet international standards to lead the chemical industry.
Product Portfolio:
Rheollose® (Sodium Carboxymethyl Cellulose): A cellulose gum used as a thickening and stabilizing agent in various applications.
Disolwell® (Croscarmellose Sodium): A super disintegrant used in oral pharmaceutical formulations to enhance tablet disintegration.
Swellcal® (Calcium Carboxymethyl Cellulose): Used as a super disintegrant in pharmaceutical applications.
AmyloTab™ (Pregelatinized Starch): Used in tablet formulations to aid in the disintegration and dissolution processes.
As of March 31, 2025, the company has a total strength of 136 employees.
Investment Objective
General corporate purposes